VKTX: Utang jangka cendhak perusahaan Viking Therapeutics, Inc.
Historical short-term debt data provided by GURU.Markets analytics demonstrate the financial trajectory of Viking Therapeutics (VKTX). Growth is driven by the development of breakthrough obesity treatments VK2809 and VK2735. Stability is ensured by US-based R&D centers focused on innovative therapies. Potential is expanding due to colossal demand in metabolic disorder markets, while the 0.01 level serves as a critical benchmark.
Ringkesan rincian data analitis Viking Therapeutics Corp (VKTX)
- kuotasi saiki lan rata-rata prakiraan nilai:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- rincian utang lan likuiditas:
Utang marang Ekuitas Viking Therapeutics|VKTX - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Viking Therapeutics|VKTX - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Viking Therapeutics, Inc.|VKTX - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Viking Therapeutics|Indikator likuiditas cepet vikingtherapeutics.com
- indikator bathi lan kelipatan valuasi:
Analisis fundamental perusahaan:VKTX - Viking Therapeutics, Inc.
Brian Lian's lean capital management in the development of obesity drugs makes the analysis of total current liabilities a key tool for assessing the operational resilience of Viking Therapeutics (VKTX). This indicator aggregates all payments maturing within one year, allowing investors to use the chart's dynamics to determine the balance between the pace of clinical trials and the risk of a liquidity shortage.
Pesaing langsung
BIIB - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan NBIX (Neurocrine)|Regencell (RGC) - Utang jangka cendhak perusahaan|Utang jangka cendhak Axsome Corp (AXSM)|Kewajiban jangka cendhak perusahaan ACAD|Utang jangka cendhak perusahaan XENE|Utang jangka cendhak perusahaan SUPN|Gunggunge utang jangka cendhak Catalyst Pharma|Utang jangka cendhak perusahaan Denali Therapeutics Inc DNLI|Utang jangka cendhak perusahaan Harmony Corp HRMY|Biohaven Ltd. - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak amylyx.com AMLX|Trevi Therapeutics, Inc. (TRVI) - Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan PRAX|AVXL (Anavex Corp) - Utang jangka cendhak perusahaan|CBLL - Tanggungan jangka cendhak|Kewajiban jangka cendhak perusahaan PRTA (Prothena)|ALEC (alector.com) - Silihan lan utang jangka cendhak perusahaan|Annexon - Kewajiban jangka cendhak perusahaan|Gedhene kewajiban jangka cendhak OMER (Omeros Corp)|Neurogene Corp - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan ACIU (AC Immune Inc)|VYGR: Utang jangka cendhak perusahaan|Utang jangka cendhak neumoratx.com (NMRA)|Utang jangka cendhak perusahaan Scilex|TVGN: Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan ACOG|Utang jangka cendhak perusahaan cogrx.com (CGTX)|Utang jangka cendhak perusahaan Inhibikase Therapeutics IKT|SAVA (cassavasciences.com) - Kewajiban jangka cendhak|Assertio Therapeutics - Utang jangka cendhak perusahaan|Utang jangka cendhak Coya Therapeutics, Inc.|VTGN (vistagen.com) - Kewajiban jangka cendhak perusahaan|Ovid Therapeutics (OVID) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan ABOS|CRVO (cervomed.com) - Gedhene kewajiban jangka cendhak|Utang jangka cendhak perusahaan ATHE|Gunggunge utang jangka cendhak clene.com|Utang jangka cendhak perusahaan PEPG (PepGen)|JUNS - Kewajiban jangka cendhak perusahaan|RLMD - Utang jangka cendhak perusahaan|Gunggunge utang jangka cendhak annovisbio.com ANVS|GRCE (gracetx.com) - Kewajiban jangka cendhak perusahaan|AIFF (Firefly Neuroscience, Inc.) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan ANEW Medical|Utang jangka cendhak perusahaan NeuroSense Therapeutics, Ltd.|Kewajiban jangka cendhak perusahaan RVPH (Reviva Pharmaceuticals)|Gedhene kewajiban jangka cendhak MTVA|NeurAxis - Kewajiban jangka cendhak perusahaan|HSDT: Tanggungan utang jangka cendhak perusahaan|PASG - Utang jangka cendhak perusahaan|NEUP (Neuphoria Therapeutics Inc.) - Tanggungan utang jangka cendhak perusahaan|NERV: Utang jangka cendhak perusahaan|Utang jangka cendhak athira.com (ATHA)|Kewajiban jangka cendhak perusahaan ADXN|Utang jangka cendhak perusahaan Alzamend|Utang jangka cendhak perusahaan Cyclerion Therapeutics (CYCN)|PTIX (protagenic.com) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Pasithea Therapeutics Corp. KTTA|Cortigent Inc (CRGT) - Utang jangka cendhak|ATXI: Kewajiban jangka cendhak perusahaan|BCLI: Utang jangka cendhak perusahaan|CARA: Utang jangka cendhak perusahaan|CHRO - Gunggunge utang jangka cendhak|Utang jangka cendhak perusahaan Eliem Therapeutics, Inc.|Utang jangka cendhak perusahaan Intra-Cellular|Utang jangka cendhak perusahaan LBPH|Gunggunge utang jangka cendhak Marinus Pharmaceuticals Inc|Utang jangka cendhak perusahaan NKGen NKGN|NRBO: Tanggungan utang jangka cendhak perusahaan|Sage Therapeutics, Inc. - Utang jangka cendhak perusahaan|Tanggungan jangka cendhak synaptogen.com (SNPX)|TRVN (Trevena) - Kewajiban jangka cendhak perusahaan|Vigil Neuroscience, Inc. - Silihan lan utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan WENA|CERE (Cerevel Corp) - Gedhene kewajiban jangka cendhak